3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
3
Helicobacter Infections
2
Gastroesophageal Reflux
2
Barrett Esophagus
2
Spinal Cord Compression
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Persistence of Infection With Helicobacter Pylori
1
Non-Erosive Reflux Disease
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Lung Neoplasms
1
Gastritis, Atrophic
1
Fatigue
1
Familial primary gastric lymphoma
1
Esophageal Neoplasms
1
Delayed Bleeding
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Cisplatin
109
Radiotherapy
100
Fluorouracil
90
Paclitaxel
75
Oxaliplatin
63
Docetaxel
56
Carboplatin
55
Irinotecan
41
Esophagectomy
41
Leucovorin
40
Capecitabine
39
Surgical Procedures, Operative
36
Radiation
36
Drug Therapy
31
Neoadjuvant Therapy
25
Chemoradiotherapy
18
Cetuximab
18
S 1 (combination)
17
pembrolizumab
16
camrelizumab
16
Nivolumab
15
Magnetic Resonance Spectroscopy
15
Bevacizumab
15
Blood Specimen Collection
14
Surveys and Questionnaires
12
Radiotherapy, Intensity-Modulated
12
Immunotherapy
11
Epirubicin
11
Biopsy
11
Trastuzumab
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Esophageal Neoplasms
×
Proton Pump Inhibitors
×
Clear all
NCT05688761
2024-06-24
NordGETS
Karolinska Institutet
Completed
900,000 enrolled